COMMITTEE: Human Rights
Question of: Prevention of Unethical Clinical Trials
Main Submitter(s): France
CO-SUBMITTERS:
CO-SPONSORS:
Recognizing
that unethical clinical trials is a crime against humanity, involving human
subjects participating in biology, clinical medicine, psychology, and other
social sciences;
Reaffirming that
clinical trial is unethical when the human subject has not given their consent;
Reiterating that the, “The Nuremberg Code” and the “Declaration of
Helinski” both have principles that should already be implemented all around
the world;
Reminding that
the definition of crimes against humanity include inhumane acts of a similar character
intentionally causing great suffering, or serious injury to body or to mental
or physical health;
Recalling that this issue can go ignored without increased amounts of
public awareness;
The General Assembly:
1.
Proposes that
an United Nations Unethical Clinical
Trial Committee, be formed to implement clauses 2 to 8;
- Calls Upon all Member States to surrender medical and employee records to the United Nations Unethical Clinical Trial Committee, so that preliminary investigations can be carried out, at facilities such as but not limited to:
a.
hospitals, clinics,
universities;
b.
the identity of patients will be
protected during the investigations;
c.
if the preliminary investigation has
yielded results, investigations will be carried out on said individual;
3.
Strongly Urges,
that a hotline will be created that will be connected to the UNUCT so that
people can anonymously report an unethical clinical trial for investigations;
4.
Expresses its hope
that the More Economically Developed Countries(MEDC’s) would regulate and
prevent the private medical corporations based in their nations from exploiting
the more vulnerable populations of the third world countries for the purpose of
their own financial gain;
a.
if the government discovers that the
private medical corporation is indeed conducting unethical clinical trials,
subsequent investigations will be carried out on said corporation;
5.
Declares that Member
States can begin increasing public awareness at appropriate age groups of
unethical clinical trials through means of but not limited to:
a. education providing means
of but not limited to:
i.
seminars, lectures;
ii. textbooks on previous unethical clinical trials,
iii. the IFMSA (International Federation of Medical Student’
Association) will raise the awareness of the
ethical concerns when conducting clinical trials to the medical
students;
b. media such as but not limited to:
i.
radio, pamphlets, internet,
television, advertisement;
6.
Requests that all
Member States to provide full co-operation with regional offices of the UNUCTC,
when apprehending a suspected individual;
- with consent of the nations involved, allow the UNUCTC to extradite criminals in cases of unethical clinical trials, and try the criminals in an international criminal court,
i.
if the local law enforcement are
compromised by intervention from third-party individuals, either financially or
physically, then the International Criminal Court should have jurisdiction of
such cases and enforce UN mandates,
ii.
suspects will be tried under the ICC,
under the grounds of crimes against humanity,
7.
Urges that
member nations with current hospitals conducting clinical trials to ensure that
all clinical trials’ information is updated frequently on the International
Clinical Trials Registry Programme;
a. countries must ensure
that future approved clinical trials to be imputed onto the ICTRP;
8.
Further Requests
that all Member States to begin setting up rehabilitation centers with
individual departments focusing on the different tests run on victims for the
purpose of restoring confidence in victims towards safe medical facilities
which includes such but not limited to
a.
Sanctioned Medical Personnel, Counseling Facilities;
9.
Further Invites
those member nations with victims of said unethical clinical trials to begin
remunerating the victims financially;
- Suggests that a meeting should be held every five years to review the status of the implementation of clauses 2-8, and will be open to member nations, doctors, and other respected members of the medical community.
